2,2'-(((2-Chloro-9-isopropyl-9H-purin-6-yl)azanediyl)bis(methylene))diphenol

Catalog No. :
ACTRTT449
CAS No. :
1076199-83-1
Molecular Formula :
C22H22ClN5O2
Molecular Weight :
423.90

IUPAC Name:2,2'-(((2-chloro-9-isopropyl-9H-purin-6-yl)azanediyl)bis(methylene))diphenol

2,2'-(((2-Chloro-9-isopropyl-9H-purin-6-yl)azanediyl)bis(methylene))diphenol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,2'-(((2-Chloro-9-isopropyl-9H-purin-6-yl)azanediyl)bis(methylene))diphenol
IUPAC Name2,2'-(((2-chloro-9-isopropyl-9H-purin-6-yl)azanediyl)bis(methylene))diphenol
MDL No.MFCD16293796
Molecular FormulaC22H22ClN5O2
Molecular Weight423.90
SMILESCC(N1C=NC2=C(N(CC3=CC=CC=C3O)CC4=CC=CC=C4O)N=C(Cl)N=C12)C
InChI KeyVQPSNEQQJJUAQM-UHFFFAOYSA-N
Synonym2-Chloro-6-[n,n-di(2-hydroxybenzyl)amino]-9-isopropylpurine;2,2'-[[[2-Chloro-9-(1-Methylethyl)-9H-purin-6-yl]iMino]bis(Methylene)]bis-phenol;Phenol, 2,2'-[[[2-chloro-9-(1-methylethyl)-9H-purin-6-yl]imino]bis(methylene)]bis-;2,2'-(((2-Chloro-9-isopropyl-9H-purin-6-yl)azanediyl)bis(methylene))diphenol
CAS No.1076199-83-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTRTT449 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTRTT449 route product structure diagram
    ACTRTT4491076199-83-1
Inquiry

2. ACTRTT449 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTRTT449 route product structure diagram
    ACTRTT4491076199-83-1
Inquiry

Comments (0)